Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rapid Micro BiosystemsRPID -5.42%56 Earnings per Share (Diluted) is $-1.12 as of Jun. 2026. GuruFocus rates RPID with a GF Score™ of 56/100 and a GF Value™ of $1.91 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 662 Medical Devices & Instruments companies, Rapid Micro Biosystems ranks better than 52.72% on this metric.
During the past 3 years, the average EPS without NRIGrowth Rate was 9.80% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 9.70% per year.
During the past 7 years, Rapid Micro Biosystems's highest 3-Year average EPS without NRI Growth Rate was 29.60% per year. The lowest was -12.90% per year. And the median was 3.15% per year.
Rapid Micro Biosystems (NAS:RPID) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Rapid Micro Biosystems Earnings per Share (Diluted) Related Terms
Rapid Micro Biosystems Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Rapid Micro Biosystems's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rapid Micro Biosystems Earnings per Share (Diluted) Chart
RPID vs CVRX, ZOMDF, SERA: Earnings per Share (Diluted) Comparison
For the Medical Devices subindustry, Rapid Micro Biosystems's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rapid Micro Biosystems PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Rapid Micro Biosystems's PE Ratio distribution charts can be found below:
* The bar in red indicates where Rapid Micro Biosystems's PE Ratio falls into.
Rapid Micro Biosystems Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Rapid Micro Biosystems's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.12
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $-1.12 mean?
Rapid Micro Biosystems (RPID) has a Earnings per Share (Diluted) of $-1.12 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Rapid Micro Biosystems and its competitors. According to the industry distribution chart, Rapid Micro Biosystems ranks #313 out of 662 companies in the Medical Devices & Instruments industry, placing it in the top 47.3%.
Is Rapid Micro Biosystems' Earnings per Share (Diluted) too high?
Rapid Micro Biosystems' current Earnings per Share (Diluted) is $-1.12. Based on the distribution chart, Rapid Micro Biosystems ranks #313 out of 662 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Rapid Micro Biosystems has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rapid Micro Biosystems' Earnings per Share (Diluted) compare to CVRX and ZOMDF?
According to the Medical Devices & Instruments industry distribution chart, Rapid Micro Biosystems ranks #313 out of 662 companies for Earnings per Share (Diluted). This puts Rapid Micro Biosystems in the upper half of its industry. The industry median Earnings per Share (Diluted) is 7.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Medical Devices & Instruments company?
The median Earnings per Share (Diluted) among Medical Devices & Instruments companies is 7.75, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Rapid Micro Biosystems and its competitors. For the Medical Devices & Instruments industry, the median Earnings per Share (Diluted) is 7.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rapid Micro Biosystems's current Earnings per Share (Diluted) is $-1.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rapid Micro Biosystems stock overvalued right now?
Based on GuruFocus' analysis, Rapid Micro Biosystems (RPID) is currently considered Possible Value Trap. The stock's GF Value™ is $1.91, compared to a current price of $1.30 — trading 31.9% below its estimated fair value. The current Earnings per Share (Diluted) is $-1.12. Rapid Micro Biosystems' overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Rapid Micro Biosystems (RPID), the current Earnings per Share (Diluted) is $-1.12 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rapid Micro Biosystems (RPID) Overvalued in 2026?
Based on GuruFocus' analysis, Rapid Micro Biosystems stock appears to be undervalued.
The current stock price of $1.30 is trading 31.9% below its estimated GF Value™ of $1.91.
GuruFocus considers Rapid Micro Biosystems to be Possible Value Trap.
Key valuation signals for RPID:
Earnings per Share (Diluted): $-1.12
GF Value™: $1.91 vs. price of $1.30 (31.9% below fair value)
No single metric tells the full story. See the RPID stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.
56GF Score
Get the complete analysis for RPID
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RPID has been successfully added to your 
